Keyphrases
Systematic Meta-analysis
100%
Meta-analysis
87%
Confidence Interval
60%
COVID-19
55%
Peru
38%
Randomized Controlled Trial
32%
Hydroxychloroquine
21%
Latin America (LATAM)
21%
Meta-analysis of Randomized Controlled Trials
21%
Peruvian
21%
Caribbean
18%
Helicobacter Pylori (H. pylori)
17%
Clinical Outcomes
16%
Prevalence Ratio
13%
Upper Gastrointestinal Bleeding
13%
COVID-19 Pandemic
13%
Adverse Effects
13%
Odds Ratio
12%
COVID-19 Patients
12%
All-cause Mortality
12%
Lipids
11%
Expert Panel
11%
Acute Pancreatitis
10%
Non-ulcer Dyspepsia
10%
Helicobacter Pylori Eradication
10%
Position Paper
10%
Adverse Events
9%
Symptom Severity
9%
Risk Ratio
9%
Intention to Vaccinate
9%
Hospitalized COVID-19 Patients
9%
Random Effects Model
8%
Placebo
8%
Risk of Bias
8%
High Risk
8%
Atrial Fibrillation
8%
Helicobacter Pylori Infection
8%
Network Meta-analysis
8%
Lima
7%
Lopinavir
7%
Chloroquine
7%
BISAP
7%
Severity Prediction
7%
Assessment Questionnaire
7%
Dyspepsia
7%
Primary Gastric Choriocarcinoma
7%
Hepatitis E
7%
Autoimmune Hepatitis
7%
Analytic Study
7%
Triple Therapy
7%
Early Prediction
7%
Pharmacological Therapy
7%
Older Adults
7%
Gastrointestinal Endoscopy
7%
Cardiovascular Disease
7%
Social Security
7%
Colchicine
7%
Clinical Practice Guidelines
7%
Veno-venous Extracorporeal Membrane Oxygenation (VV-ECMO)
7%
Inverse Variance
6%
Vaccination
6%
APACHE II
6%
Endoscopy
6%
PubMed
6%
Hospitalization
6%
Azithromycin
6%
Statin Intolerance
6%
Urea
5%
Embase
5%
Strength of Evidence
5%
Stroke Risk
5%
Gastric mucosa
5%
Satisfaction Degree
5%
Lipid Profile
5%
Lipoproteins
5%
Neurological Outcome
5%
Symptomatology
5%
Mitigation Strategies
5%
Relative Risk
5%
Pharmacology, Toxicology and Pharmaceutical Science
Randomized Controlled Trial
49%
Disease
37%
Coronavirinae
33%
Hydroxychloroquine
21%
Adverse Event
21%
Prevalence
21%
Symptom
19%
Infection
18%
All Cause Mortality
17%
Helicobacter Pylori
14%
Observational Study
11%
Coronary Artery Disease
11%
Dyspepsia
10%
Ulcer
10%
Malignant Neoplasm
10%
Random Effects Model
10%
Heart Infarction
9%
Statin (Protein)
9%
Cardiovascular Disease
8%
Placebo
8%
Lopinavir Plus Ritonavir
7%
Acute Coronary Syndrome
7%
Bacterial Endocarditis
7%
Nutraceutical
7%
Colchicine
7%
Nonalcoholic Fatty Liver
7%
Dalteparin
7%
Ivermectin
7%
Sepsis
6%
Helicobacter Infection
6%
Bleeding
6%
Cardiovascular Mortality
5%
Medicine and Dentistry
Systematic Review
64%
Meta-Analysis
56%
COVID-19
21%
Neoplasm
20%
Randomized Controlled Trial
17%
Prevalence
16%
Biopsy
12%
Helicobacter Pylori
10%
Symptom
9%
Adverse Event
9%
Upper Gastrointestinal Bleeding
8%
Disease
8%
Cohort Analysis
7%
Atrial Fibrillation
7%
Choriocarcinoma
7%
Ulcer
7%
Dyspepsia
7%
Venous Thromboembolism
7%
Dalteparin Sodium
7%
Apixaban
7%
Gastrointestinal Endoscopy
7%
Ivermectin
7%
Infection
7%
Apoplexy
6%
Endoscopy
6%
Percutaneous Coronary Intervention
6%
Epigastric Pain
6%
Melena
6%
Helicobacter Infection
5%
Placebo
5%
Network Meta-Analysis
5%
Coronavirinae
5%
All Cause Mortality
5%
Stomach Mucosa
5%